22nd Century Group Inkomsten in het verleden
Verleden criteriumcontroles 0/6
22nd Century Group's earnings have been declining at an average annual rate of -26.4%, while the Tobacco industry saw earnings growing at 13.1% annually. Revenues have been declining at an average rate of 0.8% per year.
Belangrijke informatie
-26.4%
Groei van de winst
-3.5%
Groei van de winst per aandeel
Tobacco Groei van de industrie | 18.1% |
Inkomstengroei | -0.8% |
Rendement op eigen vermogen | n/a |
Nettomarge | -267.7% |
Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Market Participants Recognise 22nd Century Group, Inc.'s (NASDAQ:XXII) Revenues Pushing Shares 1,233% Higher
Apr 02Time To Worry? Analysts Just Downgraded Their 22nd Century Group, Inc. (NASDAQ:XXII) Outlook
Aug 20With 22nd Century Group, Inc. (NASDAQ:XXII) It Looks Like You'll Get What You Pay For
Jun 14Does 22nd Century Group (NASDAQ:XXII) Have A Healthy Balance Sheet?
Jan 1322nd Century adds Creager as distribution partner for its VLN cigarettes in Colorado
Oct 03Opbrengsten en kosten
Hoe 22nd Century Group geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Jun 24 | 19 | -51 | 17 | 2 |
31 Mar 24 | 19 | -63 | 24 | 2 |
31 Dec 23 | 22 | -65 | 31 | 3 |
30 Sep 23 | 27 | -101 | 33 | 2 |
30 Jun 23 | 27 | -41 | 36 | 2 |
31 Mar 23 | 30 | -38 | 35 | 3 |
31 Dec 22 | 28 | -37 | 32 | 4 |
30 Sep 22 | 49 | -47 | 39 | 5 |
30 Jun 22 | 39 | -44 | 31 | 5 |
31 Mar 22 | 30 | -36 | 28 | 4 |
31 Dec 21 | 31 | -33 | 26 | 4 |
30 Sep 21 | 23 | -25 | 23 | 4 |
30 Jun 21 | 25 | -20 | 19 | 4 |
31 Mar 21 | 28 | -21 | 17 | 4 |
31 Dec 20 | 28 | -20 | 15 | 4 |
30 Sep 20 | 28 | -20 | 13 | 4 |
30 Jun 20 | 27 | -26 | 14 | 6 |
31 Mar 20 | 27 | -29 | 13 | 7 |
31 Dec 19 | 26 | -27 | 13 | 8 |
30 Sep 19 | 26 | -29 | 11 | 10 |
30 Jun 19 | 26 | -13 | 9 | 12 |
31 Mar 19 | 27 | -11 | 9 | 15 |
31 Dec 18 | 26 | -8 | 9 | 15 |
30 Sep 18 | 25 | -3 | 9 | 13 |
30 Jun 18 | 24 | -12 | 9 | 9 |
31 Mar 18 | 20 | -9 | 9 | 5 |
31 Dec 17 | 17 | -13 | 8 | 3 |
30 Sep 17 | 14 | -12 | 8 | 3 |
30 Jun 17 | 13 | -11 | 7 | 3 |
31 Mar 17 | 11 | -11 | 7 | 2 |
31 Dec 16 | 12 | -12 | 8 | 2 |
30 Sep 16 | 12 | -12 | 8 | 2 |
30 Jun 16 | 11 | -12 | 8 | 2 |
31 Mar 16 | 11 | -10 | 8 | 2 |
31 Dec 15 | 9 | -11 | 9 | 2 |
30 Sep 15 | 6 | -14 | 11 | 1 |
30 Jun 15 | 3 | -14 | 12 | 1 |
31 Mar 15 | 1 | -14 | 12 | 1 |
31 Dec 14 | 1 | -16 | 9 | 1 |
30 Sep 14 | 8 | -18 | 6 | 1 |
30 Jun 14 | 8 | -30 | 4 | 1 |
31 Mar 14 | 8 | -29 | 4 | 1 |
31 Dec 13 | 7 | -26 | 4 | 1 |
Kwaliteitswinsten: XXII is currently unprofitable.
Groeiende winstmarge: XXII is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: XXII is unprofitable, and losses have increased over the past 5 years at a rate of 26.4% per year.
Versnelling van de groei: Unable to compare XXII's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: XXII is unprofitable, making it difficult to compare its past year earnings growth to the Tobacco industry (2.3%).
Rendement op eigen vermogen
Hoge ROE: XXII's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.